The VEGF pathway also activates the Rac1GTPase, which in turn inhibits the Hippo kinase LATS, thus ultimately promoting the activation of TAZ, which can reprogram cancer cells into cancer stem cells (Piccolo et al., 2014; Elaimy et al., 2018). Here, VEGFA is linked to cancer.